Current status of immunotherapy in neoplasms
Diaz-Rubio García, E.
Revista Clinica Espanola 139(6): 487-496
1975
ISSN/ISBN: 0014-2565 PMID: 766120 Document Number: 85218
Document emailed within 1 workday
Related Documents
Malling, H.J. 1994: Current status of allergen-specific immunotherapy Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 1994(87): 169-77; Discussion 178-80Holmes, E.C.; Eilber, F.R.; Morton, D.L. 1975: Immunotherapy of malignancy in humans. Current status JAMA 232(10): 1052-1055
Pilch, Y.H.; deKernion, J.B. 1974: Immunotherapy of cancer with "immune" RNA: current status Seminars in Oncology 1(4): 389-395
Jarisch, R.; Hemmer, W. 1996: Specific immunotherapy in allergies--evaluation of current status Wiener Medizinische Wochenschrift 146(15): 422-425
Klotz, S.D.; Sweeney, M.J. 1983: Current status of immunotherapy in stage IV renal adenocarcinoma Journal of the Florida Medical Association 70(1): 39-42
Ondič, O.; Slunéčko, R.; Svajdler Ml, Mán. 2014: Current status of urinary cytology in the evaluation of bladder neoplasms Ceskoslovenska Patologie 50(4): 142-145
Trepel, F. 1971: Immunotherapy of neoplasms Medizinische Klinik 66(7): 222-229
Matthias, M. 1975: Chemo- and immunotherapy of malignant neoplasms Zeitschrift für Arztliche Fortbildung 69(11): 580-584
Zduńczyk, A. 1980: Transfer factor (its use in immunotherapy of neoplasms and other diseases) Wiadomosci Lekarskie 33(11): 877-881
Mellstedt, H.åk.; Veelken, H. 2005: Active immunotherapy in patients with hematologic and solid neoplasms Onkologie 28(Suppl 4): 4-8
Hashimoto, Y.; Nishimura, T. 1979: Immunotherapy of neoplasms, with special reference to the destruction of neoplastic cells Nihon Rinsho. Japanese Journal of Clinical Medicine 37(7): 2872-2877
Grinevich, I.A. 1991: Nonspecific active immunotherapy in the combined treatment of malignant neoplasms Vrachebnoe Delo 5: 8-11
Carballido, J.; Alvarez-Mon, M.; Olivier, C.; Moltó, L. 1990: Immunotherapy of urothelial neoplasms. Experimental and clinical implications of alpha interferon Archivos Espanoles de Urologia 43(Suppl 2): 149-158
Sugimachi, K.; Ageo, H.; Natsuda, Y.; Yasaka, A.; Nakamura, T. 1979: Postoperative long-term chemotherapy combined with immunotherapy in esophageal neoplasms Nihon Kyobu Geka Gakkai 27(4): 504-506
Tigaud, J.M.; Duarte, A.; Psyche, S.; Droz, J.P. 1991: Current data on immunotherapy Revue de l'Infirmiere 41(19): 30-31
Stone, D.; Imbeau, S.; Moyer, J. 2000: Current concepts in allergen immunotherapy Journal of the South Carolina Medical Association 96(5): 218-220
Riera, L.; Koziner, B. 2000: Donor lymphocyte infusions as adoptive immunotherapy in patients with relapsed hematologic neoplasms post-allogenic transplant of hematopoietic progenitor cells Medicina 60(2): 259-269
Amiel, J.L. 1977: Chemotherapy and immunotherapy of cancer. Current advances Semaine des Hopitaux. Therapeutique 53(9): 473-474
Mastrangelo, M.J.; Berd, D.; Maguire, H.C. 1984: Current condition and prognosis of tumor immunotherapy: a second opinion Cancer Treatment Reports 68(1): 207-219
Aliaev, I.G.; Grigorian, V.A.; Shpot', E.V. 2007: Current modalities in immunotherapy of renal cell carcinoma Terapevticheskii Arkhiv 79(6): 78-82